Blog
RSS FeedPosted by Michael Wonder on 10 Aug 2019
Government of Canada announces changes to lower drug prices and lay the foundation for National Pharmacare
9 August 2019 - Today, the Government of Canada announced the final amendments to the Patented Medicines Regulations. ...
Posted by Michael Wonder on 31 Jul 2019
Two powerful Canadian provinces argued against federal drug price crackdown
31 July 2019 - Canada’s two most populous provinces, Ontario and Quebec, have privately expressed concerns with a federal government plan ...
Posted by Michael Wonder on 24 Jun 2019
Forcing patients to switch to biosimilars puts them in uncharted waters
23 June 2019 - On May 27, the B.C. government announced a policy that will forcibly switch thousands of patients, ...
Posted by Michael Wonder on 12 Jun 2019
Canada will move on new drug price rules in 'very near future': minister
13 June 2019 - Work on the Canadian government’s proposal to crack down on patented drug prices is underway and ...
Posted by Michael Wonder on 03 Jun 2019
Canada to limit scope of new drug price rules
29 May 2019 - The federal government has assured the pharmaceutical industry that new features of its plan to cut ...
Posted by Michael Wonder on 29 May 2019
Canada told drug makers it would limit scope of some new price rules
29 May 2019 - The Canadian government has assured the pharmaceutical industry that new features of its plan to cut ...
Posted by Michael Wonder on 27 May 2019
'You disappointed us': Why is Canada opposing more transparency in drug prices?
25 May 2019 - Pharma industry says high prices are necessary to cover costs. Some nations want to see the data. ...
Posted by Michael Wonder on 08 May 2019
In Canada, a little known drug regulator shows its teeth
8 May 2019 - A tiny, little-known government agency is ramping up regulation of Canada’s pharmaceutical industry, seeking to rein in ...
Posted by Michael Wonder on 10 Apr 2019
Canada needs to read the fine print on pharma costs
10 April 2019 - The proposed federal price controls for patented medicines will send the wrong signal to Canadian and global ...
Posted by Michael Wonder on 29 Mar 2019
Canada’s amendment to patented drug price regulation: a prescription for global drug cost control?
29 March 2019 - The cost of drugs in the United States has emerged as a focal point for reducing overall ...
Posted by Michael Wonder on 22 Mar 2019
Ontario may lift ban preventing major pharmacies from selling private-label generic drugs
21 March 2019 - Ontario Premier Doug Ford’s government is considering lifting a ban that prevents major pharmacy chains from ...
Posted by Michael Wonder on 28 Feb 2019
Drug prices aren’t a big problem, but Ottawa’s trying to control the market anyway
28 February 2019 - New policies will reduce access to new medicines for patients and impose massive new costs on taxpayers. ...
Posted by Michael Wonder on 21 Feb 2019
Canada finds "insufficient evidence" that Janssen blocked biosimilar competition
21 February 2019 - Despite the fact that the investigation confirmed many of the allegations against Janssen, the bureau concluded that, ...
Posted by Michael Wonder on 20 Feb 2019
New drug landscape dominated by high cost medicines
19 February 2019 - The Patented Medicine Prices Review Board, through the National Prescription Drug Utilization Information System research initiative, ...
Posted by Michael Wonder on 09 Feb 2019
U.S. PhRMA's fight to prevent lower Canadian drug prices
9 February 2019 - Drug industry turns up heat against Canada's drug price reforms. ...